Illumina Stock May Illuminate This Healthcare ETF

Biotech firm Illumina, Inc. ( ILMN ) scrapped a merger with Pacific Biosciences, but there’s still a lot to like about Illumina and for investors that can’t handle the stock’s over $300 price tag, the ARK Genomic Revolution Multi-Sector Fund ( ARKG ) is an adequate proxy on the stock.